Comvita Limited · NZX:CVT

Comvita — H1 FY2024 Earnings Presentation

62 slides from Comvita's earnings presentation, Feb 21, 2024

  1. Slide 1: Investor Presentation Half Year Results FY24

    PRESENTED BY: INVESTOR PRESENTATION David Banfield, CEO HALF YEAR RESULTS FY24 Nigel Greenwood, CFO 21 FEBRUARY 2024 Poised F O R TA K E - O F F

  2. Slide 2: Important Notice

    I M P O R TA N T Notice This presentation is given on behalf of Comvita Limited. Comvita’s audited financial statements. We monitor • Is for general information purposes only and does not Information in this presentation: these non-GAAP measures as key performance constitute investment advice. indic

  3. Slide 3: Key Messages

    OUR HY24 Key Messages • Interim results are consistent with Comvita’s trading updated dated 1st February 2024 • Recent guidance changes for H2-24 factor in lower consumer spending in China and the loss of some distribution with one customer in North America • Early signs of improvement in China duri

  4. Slide 4: Recent Guidance Changes

    OUR HY24 Recent Guidance Changes February trading and guidance update • Mainland China – FY24 1H revenue was $33M, down 19% on PCP. Driven by macro-economic weakness, impacting the premium consumer category. Sales in Mainland China are showing improvement towards a more stable trading pattern • Nort

  5. Slide 5: Focus on Greater China

    FOCUS ON Greater China • Revenue challenges in mainland China due to broader macro economic issues • 11.6% CAGR 2019 to 2024 • Signs of improvement between quarters (Q1 and Q2) and in January, Q2 flat with Q2 FY22 • Hong Kong SAR reporting single digit improvement vs PCP • Market share remains stron

  6. Slide 6: Targeting $50M EBITDA 2025 (20%)

    TA R G E T I N G $50M EBITDA 2025 (20%) COMVITA 50:2025 60 : 15 : 20 MINIMUM 60% GP 15% MARKETING TO SALES RATIO 20% EBITDA TARGET Gross Profit (%) Marketing Investment (%) EBITDA excl ERP cost (%) FY24 Forecast (mid point) FY24 Forecast (mid point) FY24 Forecast (mid point) 70% 16% 16% 60% 14% 14%

  7. Slide 7: Financials

    SECTION GROWING SHARE IN FOCUS MARKETS Financials

  8. Slide 8: Financial Summary

    OUR HY24 Financial Summary • Interim revenue $103.4M ( -7.8% vs PCP) • HoneyWorld revenue $6.8M • GP 60% or $62.2M -170 bps vs PCP in line with our plan • Marketing investment $14M or 13.5% to sales • ERP and transformation investment $4.4M • EBITDA excl ERP $9.5M -32% vs PCP • NPAT -$3.2M vs $4.2M

  9. Slide 9: Financial Key Results: Income Statement

    K E Y R E S U LT S Financial I N C O M E S TAT E M E N T For the year ended 31 December 31 December NZD 000s 2023 2022 Variance $ Variance % • Revenue decreased -7.8% vs PCP Revenue 103,365 112,130 (8,765) (7.8%) • GP% down 1.7% vs PCP due to gains of $3M in Gross Profit 62,176 69,380 (7,204) (10.4%

  10. Slide 10: Financial Key Results: Balance Sheet

    K E Y R E S U LT S FinancialBALANCE SHEET As at 31 31 NZD 000s December December 2023 2022 Variance $ • Net debt $85.8M – up $22.5M or +35.6% on Net Debt 85,816 63,279 22,537 PCP Operating Cashflow (6,110) (18,606) 12,496 • HoneyWorld acquisition and Apiter Inventory 143,405 145,844 (2,439) investme

  11. Slide 11: Inventory

    Inventory As at 31 31 NZD 000s December December 2023 2022 Variance $ • While inventory has decreased by $2.4M vs PCP it Raw Materials 68,892 89,006 (20,114) remains at elevated levels Work in Progress 4,514 4,011 503 • Raw materials decreased by $20.1M reflecting the Finished Goods 69,999 52,827 17

  12. Slide 12: Cashflow

    Cashflow For the year ended 31 31 NZD 000s December December 2023 2022 Variance $ • Operating cashflow (-$6.1M), $12.5M Operating cash inflow (6,110) (18,606) 12,496 improvement on prior year: Investing activities (17,188) (12,202) (4,986) • Predominantly impacted by increase in Financing activities

  13. Slide 13: FY24 Interim Dividend

    FY24 Interim Dividend • Directors have declared a fully imputed interim dividend of 1 cps • Reflecting the softer first half trading • Comvita remains committed to balancing shareholder distributions with prudent capital management • The board will review our full year dividend in August • Record da

  14. Slide 14: ERP on Track

    KEY PROJECT ERP on Track FY24 HY24 investment $3.4M (included in this result) • Upgrade of existing ERP system to latest version – re-implementation • On track to complete June FY24 latest, • Total FY24 investment of $7M • Reviews and updates: • Master data • End to end processes • Ways of working B

  15. Slide 15: Market Segments

    SECTION Market Segments GROWING SHARE IN FOCUS MARKETS

  16. Slide 16: Segment Performance

    HY24 Segment Performance Revenue and contribution performance – segments in HY24 • Revenue -$8.8M or -7.8% vs PCP • Greater China revenue drop impacted by broader economic challenges / consumer spending − Greater China revenue -$6.9M or -13.3% − Contribution dropped in line with sales − Mainland Chi

  17. Slide 17: Greater China

    GREATER CHINA ON A REPORTED CURRENCY BASIS – FOR 6 MONTHS ENDED DEC 23 This Year Last Year Vs. Vs. NZD 000s Dec-23 Dec-22 Last Year Last Year % Sales 45,007 51,916 (6,909) (13.3%) Net Contribution 8,482 13,066 (4,584) (35.1%) Net Contribution % 18.8% 25.2% (6.3%) • Revenue down -13.3% or -$6.9M in f

  18. Slide 18: Greater China Growth

    EXCITING FUTURE Greater China GROWTH HALF 1 FY19 FY24 SALES $26M $45M FULL YEAR FY19 FY24 SALES $77M $99M • H1 revenue -13.3 % vs PCP • H2 forecast revenue -5% to -10% vs PCP • FY24 forecast revenue -7.5% to -11.5% vs PCP COMVITA INVESTOR PRESENTATION HALF YEAR RESULT FY24 18

  19. Slide 19: North America

    NORTH AMERICA ON A REPORTED CURRENCY BASIS – FOR 6 MONTHS ENDED DEC 23 This Year Last Year Vs. Vs. NZD 000s Dec-23 Dec-22 Last Year Last Year % Sales 13,029 20,699 (7,669) (37.1%) Net Contribution 2,298 6,977 (4,679) (67.1%) Net Contribution % 17.6% 33.7% (16.1%) • Total revenue of $13M is down $7.7

  20. Slide 20: North America Growth

    EXCITING FUTURE North America GROWTH HALF 1 FY19 FY24 SALES $8M $13M FULL YEAR FY19 FY24 SALES $13M $26M • H1 revenue -37.1% vs PCP • H2 forecast revenue -10% to -15% vs PCP • FY24 forecast revenue -25% to -30% vs PCP COMVITA INVESTOR PRESENTATION HALF YEAR RESULT FY24 20

  21. Slide 21: Rest of Asia

    REST OF ASIA ON A REPORTED CURRENCY BASIS – FOR 6 MONTHS ENDED DEC 23 This Year Last Year Vs. Vs. NZD 000s Dec-23 Dec-22 Last Year Last Year % Sales 19,213 12,925 6,288 48.7% Net Contribution 2,600 3,314 (714) (21.5%) Net Contribution % 13.5% 25.6% (12.1%) • Strong sales growth +49% vs PCP to $19.2M

  22. Slide 22: Rest of Asia Growth

    EXCITING FUTURE Rest Of Asia GROWTH HALF 1 FY19 FY24 $9M $19M FULL YEAR FY19 FY24 $17M $45M • H1 revenue +48.7% vs PCP • H2 forecast revenue +32% to +38% vs PCP • FY24 forecast revenue +40% to +45% vs PCP • On track to become second biggest segment COMVITA INVESTOR PRESENTATION HALF YEAR RESULT FY24

  23. Slide 23: Australia + New Zealand

    AUSTRALIA + NEW ZEALAND ON A REPORTED CURRENCY BASIS – FOR 6 MONTHS ENDED DEC 23 This Year Last Year Vs. Vs. NZD 000s Dec-23 Dec-22 Last Year Last Year % Sales 19,255 18,074 1,181 6.5% Net Contribution 6,216 6,326 (110) (1.7%) Net Contribution % 32.3% 35.0% (2.7%) • Revenue $19.3M +6.5% vs PCP • Chi

  24. Slide 24: ANZ Growth

    EXCITING FUTURE ANZ GROWTH HALF 1 FY19 FY24 $30M $19M FULL YEAR FY19 FY24 $62M $44M • H1 revenue +6.5% vs PCP • H2 forecast revenue +7.5% to +12.5% vs PCP • FY24 forecast revenue +6% to +11% vs PCP COMVITA INVESTOR PRESENTATION HALF YEAR RESULT FY24 24

  25. Slide 25: EMEA

    EMEA ON A REPORTED CURRENCY BASIS – FOR 6 MONTHS ENDED DEC 23 This Year Last Year Vs. Vs. NZD 000s Dec-23 Dec-22 Last Year Last Year % Sales 2,159 2,530 (371) (14.7%) Net Contribution (36) 7 (43) (589.3%) Net Contribution % (1.7%) 0.3% (2.0%) • $2.2M revenue -14.7% vs PCP • Segment remains subscale

  26. Slide 26: Ecommerce

    ECOMMERCE 40.0 % + 7 % + 46.9 % + 46 BPS ECOMMERCE SHARE EMAIL DATABASE vs PCP REGISTERED USERS CONVERSION RATE vs PCP +120 BPS vs PCP GROWTH vs PCP +1,300 BPS +585 % +7.9 % + 162 % REPEAT PURCHASE RATE vs PCP CHAMPION USERS vs PCP US ECOMMERCE US AMAZON REVENUE vs PCP GROWTH vs PCP COMVITA INVESTOR

  27. Slide 27: FY24 Guidance

    SECTION FY24 Guidance

  28. Slide 28: FY24 Guidance

    FY24 Guidance FY24 Forecast reflects weaker consumer spending, with some improvement on HY • Revenue $225M – $235M  FY24 gross profit forecast of 60%  EBITDA excluding ERP costs $30M – $35M  Net debt reduced, due to positive operating cashflow  FY24 forecast inventory decline vs PCP On target to

  29. Slide 29: Revenue Bridge to FY24

    Revenue Bridge to FY24 MID-POINT H1 H2 FY2024 • Greater China assumes some recovery on H1 during H2, however H2 forecast to be H2 down 5.7% on PCP FY2024 FY2024 % forecast % forecast % • North America H2 sales expected to be SEGMENT (NZD 000s) H1 Variance mid- Variance mid- Variance substantially in

  30. Slide 30: Earnings Bridge to FY24

    Earnings Bridge to FY24 MID POINT H1 to FY24 EBITDA (excl ERP costs) Bridge NZ$M 76.2 (30.7) 6.0 32.5 (28.5) 9.5 H1 EBITDA Gross Profit Marketing & Other Depreciation FY24 EBITDA (excl. ERP) Sales Expenses (excl. ERP) H1-FY24 Actual H2-FY24 Forecast FY24 Forecast • The Gross Profit in H2 assumes we

  31. Slide 31: Targeting c$50M EBITDA 2025 (20%)

    TA R G E T I N G c$50M EBITDA 2025 (20%) PURPOSE + VALUES OUR MISSION TO 2025 COMVITA 50:2025 Working in harmony with bees and nature in New Zealand “To deliver world-leading standards for our team, our consumers, our 60 : 15 : 20 to heal and protect the world shareholders and our planet, contributi

  32. Slide 32: Strong Platform for Long-term Growth

    SECTION BEYOND FY24 Strong Platform for Long-term Growth

  33. Slide 33: Purpose & Values

    Purpose & Values COMVITA INVESTOR PRESENTATION HALF YEAR RESULT FY24 33

  34. Slide 34: Focus & Progress

    CLARITY OF Focus & Progress TO 2025 COMVITA INVESTOR PRESENTATION HALF YEAR RESULT FY24 34

  35. Slide 35: Business Model Proving Successful

    MARKET LEADER MARKET MĀNUKA HONEY MARKET SHARE LEADER Business Model MARKET Proving LEADER Successful MARKET LEADER MARKET LEADING IN 5 OUT OF 6 OF OUR KEY MARKETS MARKET LEADER TOP COMVITA INVESTOR PRESENTATION HALF YEAR RESULT FY24 2 - 3 B R A35 ND

  36. Slide 36: Premiumisation

    T H E E V O L U T I O N O F C O M V I TA Premiumisation COMVITA INVESTOR PRESENTATION HALF YEAR RESULT FY24 R E TA I L P R E S E N C E I N S T O R E S CIIE 2023 36

  37. Slide 37: Highest Quality Premium Brand

    T H E E V O L U T I O N O F C O M V I TA Highest Quality Premium Brand NY TIMES SQUARE CLAUDIA LI / NY FASHION WEEK A U C K L A N D M A R AT H O N COMVITA INVESTOR PRESENTATION HALF YEAR RESULT FY24 37

  38. Slide 38: Premium Brand Partners

    T H E E V O L U T I O N O F C O M V I TA Premium Brand Partners KO R E A G R A N D H YAT T H I G H T E A COMVITA INVESTOR PRESENTATION HALF YEAR RESULT FY24 C O L L A B O R AT I O N W I T H S N O W 5 1 38

  39. Slide 39: The Future of Retail is Experiential

    The Future of Retail is WELLNESS LAB WUXI Experiential VIRTUAL WELLNESS LAB AKL AIRPORT COMVITA INVESTOR PRESENTATION HALF YEAR RESULT FY24 39

  40. Slide 40: Building Momentum

    Revenue ($M) Gross Profit ($M) EBITDA excl ERP ($M) CAGR + 6.1% CAGR + 16.6% CAGR + 67.0% 250 160 40 Building 200 140 120 100 35 30 25 Momentum 150 80 20 100 60 15 40 10 50 20 5 64 96 103 126 139 138 - 4 26 30 34 32.5 FY24 Forecast 171 196 192 209 234 230 - - - 19 20 21 22 23 24 19 20 21 22 23 24 19

  41. Slide 41: Already Made to Build a Platform for Growth

    LAB AUTOMATION c$850K P R O D U C T / S U P P LY SCIENCE RESEARCH INVESTMENT $3.4M FY22-FY24 SCALABLE PRODUCTIONS $5.6M Investment SCIENCE & QUALITY TEAM FORESTS $7.1M FY22-FY24 c$31M 7.5K hectares Already Made ERP $10.5M investment finished FY24 to Build a PROCESS ESG INVESTMENT c$750K pa PROCESS E

  42. Slide 42: Platform for Growth

    BUILDING Platform for Growth P O I S E D F O R TA K E O F F FY19 FY23 MARKETING INVESTMENT $ 11M 31$ M MARKETS 9 13 R E TA I L & E X P O EXCELLENCE $ 1M $3.8 M FORESTS $ 5M C$ 31.1 M 7.5K ha COMVITA INVESTOR PRESENTATION HALF YEAR RESULT FY24 42

  43. Slide 43: Exciting Future

    GLOBAL HONEY MARKET Exciting Future OUR 2030 OPPORTUNITY 2023 2030 WHY ARE WE CONFIDENT WE WILL GET THERE 14 • Core business in growing market T O TA L − US$9bn TAM forecast to grow by +55% by 2030 ADDRESSABLE M A R K E T US$ GLOBAL HONEY MARKET 9BN US$ BN • Low Mānuka honey household penetration (H

  44. Slide 44: Industry Positioning

    SECTION Industry Positioning

  45. Slide 45: Industry Strategy

    LAUNCHED 20 FEBRUARY 2024 Industry Strategy S T R AT E G I C F R A M E W O R K COMVITA INVESTOR PRESENTATION HALF YEAR RESULT FY24 45

  46. Slide 46: Supply Security

    C O M V I TA’ S S U P P LY M O D E L C O M P E T I T I V E A D VA N TA G E COMVITA’S SUPPLY STRATEGY Supply Security HARVEST MODEL AND IMPROVED GROSS MARGINS Sustainable Comvita’s product gross margin is expected to increase from c60% to >65% by 2030 as Comvita Forest in terms of result of price, gr

  47. Slide 47: Standards Tested

    HIGHEST THE MOST Standards FOR MĀNUKA Tested MĀNUKA IN THE WORLD > 23 >34 INDEPENDENT CERTS TESTS & A C C R E D I TAT I O N S O N E V E R Y B AT C H > 13 500 K G L O B A L R E S E A R C H PA R T N E R S H I P S + T E S T R E S U LT S I N T E R N AT I O N A L A D V I S O R Y B O A R D FY23 47

  48. Slide 48: Science and IP

    F U R T H E R I N V E S T M E N T I N F Y 2 4 T O D AT E Science and IP C O M V I TA L A B O R AT O R I E S E s t 1 9 7 4 Industry leading in clinical trials Industry leading Mānuka honey for digestive health enrolment $ commenced (HVN National Science Challenge grant awarded: $900K) 1.45M lab testi

  49. Slide 49: Science: International Advisory Board

    I N T E R N AT I O N A L Science ADVISORY BOARD W O R L D - L E A D I N G G A S T R O E N T E R O L O G I S T S A N D D I G E S T I V E H E A LT H R E S E A R C H E R S 49

  50. Slide 50: Lepteridine Unique and Protected

    E X T E N D E D A D VA N TA G E Lepteridine Unique and Protected LEPTERIDINE SOOTHE CLINICAL PAT E N T FA M I LY # 1 PAT E N T FA M I LY # 2 TRIAL COMVITA INVESTOR PRESENTATION HALF YEAR RESULT FY24 50

  51. Slide 51: Clinical Trials

    E X T E N D I N G O U R A D VA N TA G E Clinical Trials SOOTHE: Comvita Lepteridine ® Mānuka honey for digestive health • $1.45M investment over 2 years: $900K HVN grant • Proprietary treatment: Comvita Lepteridine ® patented Mānuka honey CONNECTING • Unique to Comvita CONSUMERS TO THE • Study compl

  52. Slide 52: Clinical Trials Pending

    E X T E N D E D A D VA N TA G E Clinical Trials PENDING C A R D I O M E TA B O L I C H E A LT H IMMUNITY AT O P I C D E R M AT I T I S ANTIMICROBIAL R E S I S TA N C E COMVITA INVESTOR PRESENTATION HALF YEAR RESULT FY24 52

  53. Slide 53: Impact

    SECTION S O C I A L A N D E N V I R O N M E N T I M PA C T Impact

  54. Slide 54: Team / Whānau

    HY24 GLOBAL Team / Whānau 595 91% + 24 GLOBAL FULL TIME EQUIVALENT (FTE) ROLES GLOBAL TEAM ARE SHAREHOLDERS (OR eNPS SCORE EQUIVALENT) COMVITA INVESTOR PRESENTATION HALF YEAR RESULT FY24 54

  55. Slide 55: ESG Leadership at Comvita

    ESG Leadership at Comvita ENVIRONMENTAL SOCIAL GOVERNANCE Key Focus Areas: Key Focus Areas: Key Focus Areas: ● GHG emissions ● Product quality and food safety ● Board composition (diversity and ● Air and water pollution ● Customer satisfaction independence) ● Biodiversity reporting ● Ethical procure

  56. Slide 56: Safety & Wellbeing

    PERFORMANCE VS PCP Safety & Wellbeing 1 J U LY 2 0 2 3 – 3 1 D E C E M B E R 2 0 2 3 3.0 1.5 + 72% TRIFR LTIFR NEAR MISS REPORTING -21% vs FY23 (3.8) -44% vs FY23 (2.7) 3.47 0.9 SAFETY CULTURE MVIFR MATURITY -69% vs FY23 (0.53) +58% vs FY23 (2.2) COMVITA INVESTOR PRESENTATION HALF YEAR RESULT FY24 5

  57. Slide 57: GHG Summary

    H1 FY24 GLOBAL GHG Summary R E S U LT S GREENHOUSE GAS EMISSIONS – GLOBAL tCO2e FY24 FY23 Difference tCO2e tCO2e % Total Gross Emissions (S1, S2, major S3) 11,940 13,431 (11%) Removals GHG Inventory (estimated for H1) (3,949) (2,925) 35% Total Net GHG Inventory Emissions (S1, S2 & Major S3) 7,991 10

  58. Slide 58: Summary

    SECTION Summary

  59. Slide 59: Exciting Future

    GLOBAL HONEY MARKET Exciting Future OUR 2030 OPPORTUNITY 2023 2030 14 T O TA L ADDRESSABLE M A R K E T US$ GLOBAL HONEY MARKET 9BN US$ BN C AT E G O R Y H O U S E H O L D P E N E T R AT I O N < 1% > 3 % C O M V I TA L I F E T I M E VA LU E + 335 % 2.2 GROWTH PRICING GROWTH + % PA REGIONAL GROWTH CHI

  60. Slide 60: Summary

    Summary • Challenging first half • Second half estimates reflect recent trading conditions and prudent cost management • Early signs of improvement in China and additional NA distribution agreements signed • Market share robust and 60% gross margin retained • Committed to FY25 strategic plan, c$50M

  61. Slide 61: Q+A

    SECTION Q+A

  62. Slide 62: Poised for Take-off

    Poised F O R TA K E - O F F

Comvita — H1 FY2024 Earnings Presentation on 6ix